UBS Maintains a 'Neutral' on West Pharmaceutical (WST); First Quarter 2011 Review
Tweet Send to a Friend
UBS maintains a 'Neutral' on West Pharmaceutical (NYSE: WST), raises PT from $45 to $48.
UBS analyst says, "Q1 sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "Q1 sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
